J0280 Aminophyllin Injection HCPCS Reimbursement

HCPCS Level II code J0280 denotes the administration of injectable aminophyllin, up to 250 mg. This drug administration code captures a specific parenteral medication service used in acute and ambulatory care settings for bronchodilation or related indications where aminophyllin is clinically appropriate. Nationally, J0280 matters for coding accuracy, billing transparency, and proper tracking of medication utilization in outpatient and emergency care.

Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of how HCPCS Level II code J0280 is classified, typical sites of service, and the clinical context for aminophyllin injections. The publication also outlines common billing considerations, including applicable modifiers and payer coverage patterns where available.

This summary provides benchmarks for coding and billing practice, highlights recent policy updates affecting injectable drug reporting, and situates J0280 within medication administration service lines. Intended readers are coding professionals, revenue cycle staff, and clinical managers seeking concise guidance on the role and reporting of aminophyllin injection services in outpatient care. Data not available in the input for payer-specific rates, taxonomies, and ICD-10 mapping are noted where relevant.

Billing Code Overview

HCPCS Level II code J0280 represents injection, aminophyllin, up to 250 mg. This code describes a parenteral medication administration service for aminophyllin provided as an injectable formulation.

Service type: Medication injection
Typical site of service: Outpatient clinic, physician office, emergency department, or other ambulatory settings where injectable medications are administered

Data not available in the input.

Clinical Context

A patient with acute bronchospasm secondary to an asthma exacerbation presents to the emergency department or urgent care with wheezing, shortness of breath, and decreased peak expiratory flow. Initial management includes inhaled bronchodilators and supplemental oxygen as needed. When inhaled therapy is insufficient or the patient is unable to tolerate inhalation (for example, severe bronchospasm, altered mental status, or failure to respond), intravenous or intramuscular methylxanthine therapy such as aminophylline (J0280 — Injection, aminophyllin, up to 250 mg) may be administered by an emergency physician, hospitalist, or critical care clinician. The clinical workflow includes assessment (vital signs, pulse oximetry), preparation and dose calculation based on weight and clinical status, documentation of indication and informed consent if required by facility policy, administration by a licensed clinician (RN, paramedic, or physician), monitoring for therapeutic effect and adverse reactions (tachycardia, arrhythmia, nausea, seizures), and follow-up orders for serum theophylline levels if continued therapy is planned. Typical sites of service are Emergency Department, Inpatient Hospital, Observation Unit, or Ambulance/Pre-hospital care when parenteral therapy is required.

Coding Specifications

Modifier	Description	When to Use
`22`	Increased procedural services	When aminophylline administration requires substantially greater resources (e.g., extended monitoring or complex dosing due to severe comorbidity).

Taxonomy Code	Specialty	Notes
`207RC0000X`	Emergency Medicine Physician	Emergency physicians commonly order/administer parenteral aminophylline for severe bronchospasm.
`208D00000X`	Critical Care Physician	Critical care specialists manage severe respiratory failure requiring parenteral bronchodilators and close monitoring.
`163WA0400X`	Pulmonology Physician	Pulmonologists may order aminophylline in inpatient settings for refractory bronchospasm and oversee follow-up levels.
`164W00000X`	Hospitalist	Hospitalists may coordinate inpatient administration and monitoring of aminophylline for admitted patients.
`363L00000X`	Registered Nurse	Registered nurses perform medication preparation, administration, and bedside monitoring per scope of practice.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`J45.901`	Unspecified asthma, unspecified, with acute exacerbation	Common indication for parenteral aminophylline in severe asthma exacerbations not responding to inhaled therapy.
`J96.00`	Acute respiratory failure, unspecified whether with hypoxia or hypercapnia	Severe bronchospasm with respiratory compromise may prompt parenteral bronchodilator therapy including aminophylline.
`J44.1`	Chronic obstructive pulmonary disease with (acute) exacerbation	In select cases with severe COPD exacerbation and bronchospasm refractory to standard therapy, aminophylline may be used.
`R06.2`	Wheezing	Symptom code that correlates with bronchospasm and potential need for parenteral bronchodilator.
`T88.7XXA`	Unspecified adverse effect of drug or medicament, initial encounter	Used if patient experiences an adverse reaction to aminophylline requiring care.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`96372`	Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular	May be used when aminophylline is administered IM in outpatient or clinic settings.
`96365`	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	Used when aminophylline is administered as an IV infusion (loading dose) requiring timed infusion reporting.
`99283`	Emergency department visit, moderate severity	Typical E/M code for patients presenting with acute bronchospasm who receive parenteral aminophylline in the ED.
`93000`	Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report	Obtained before or after aminophylline in patients at risk for arrhythmia.
`36415`	Collection of venous blood by venipuncture	Used for serum theophylline level monitoring when ongoing aminophylline/theophylline therapy is planned.

OpenPayer

Summary & Overview

HCPCS J0280: Injection, Aminophyllin, Up to 250 mg